Summit Therapeutics (SMMT) Other Gross PP&E Adjustments (2020 - 2025)
Summit Therapeutics' Other Gross PP&E Adjustments history spans 6 years, with the latest figure at -$5.4 million for Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments rose 32.05% year-over-year to -$5.4 million; the TTM value through Sep 2025 reached -$5.4 million, up 32.05%, while the annual FY2024 figure was -$19.8 million, 126.21% down from the prior year.
- Other Gross PP&E Adjustments reached -$5.4 million in Q3 2025 per SMMT's latest filing, up from -$5.6 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$1.5 million in Q1 2021 to a low of -$19.8 million in Q4 2024.
- Average Other Gross PP&E Adjustments over 5 years is -$5.9 million, with a median of -$5.6 million recorded in 2025.
- Peak YoY movement for Other Gross PP&E Adjustments: tumbled 2821.8% in 2021, then skyrocketed 36.3% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$3.6 million in 2021, then tumbled by 61.63% to -$5.9 million in 2022, then crashed by 49.39% to -$8.7 million in 2023, then plummeted by 126.21% to -$19.8 million in 2024, then surged by 72.59% to -$5.4 million in 2025.
- Per Business Quant, the three most recent readings for SMMT's Other Gross PP&E Adjustments are -$5.4 million (Q3 2025), -$5.6 million (Q2 2025), and -$6.4 million (Q1 2025).